PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
19.22%
Some net income increase while CSIQ is negative at -70.88%. John Neff would see a short-term edge over the struggling competitor.
10.08%
D&A growth of 10.08% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a mild cost difference that must be justified by expansions.
85.55%
Deferred tax of 85.55% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a partial difference that can matter for future cash flow if large in magnitude.
3.65%
SBC growth of 3.65% while CSIQ is zero at 0.00%. Bruce Berkowitz would see some additional share issuance that must be justified by expansions or retention needs.
-59.85%
Negative yoy working capital usage while CSIQ is 0.00%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
-0.82%
AR is negative yoy while CSIQ is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
79.04%
Inventory growth of 79.04% while CSIQ is zero at 0.00%. Bruce Berkowitz would see a moderate build that must match future sales to avoid risk.
-227.44%
Negative yoy AP while CSIQ is 0.00%. Joel Greenblatt would see quicker payments or less reliance on trade credit than competitor, unless expansions are hindered.
-1409.91%
Negative yoy usage while CSIQ is 0.00%. Joel Greenblatt would see a short-term advantage in freeing up capital unless competitor invests effectively in these lines.
-1356.89%
Negative yoy while CSIQ is 67.61%. Joel Greenblatt would see a near-term net income or CFO stability advantage unless competitor invests or writes down more aggressively.
-86.96%
Negative yoy CFO while CSIQ is 0.00%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
-74.34%
Negative yoy CapEx while CSIQ is 0.00%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
50.51%
Growth of 50.51% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a moderate difference requiring justification by ROI in these smaller invests.
491.42%
We expand invests by 491.42% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a moderate outflow that must be justified by returns vs. competitor’s stable approach.
63.18%
Debt repayment growth of 63.18% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a mild advantage that can reduce interest costs unless expansions demand capital here.
No Data
No Data available this quarter, please select a different quarter.
95.81%
Buyback growth of 95.81% while CSIQ is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.